华特达因：子公司获得盐酸可乐定缓释片药品注册证书

Core Viewpoint - The company Huate Dain has received a drug registration certificate from the National Medical Products Administration for its product, Clonidine Hydrochloride Sustained-Release Tablets, aimed at treating Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years [1] Group 1 - The drug is intended for use either alone or as an adjunct to central nervous system stimulants in the treatment of ADHD [1]